initiating biologic therapy -- strategies to reduce the risks of complications
Published 10 years ago • 1.2K plays • Length 33:59Download video MP4
Download video MP3
Similar videos
-
19:39
biologics in cancer
-
19:34
preventing infections in patients treated with biologics
-
14:54
rheumatoid arthritis: non-biologic therapy and metrics - ep. 7
-
28:06
management of co-morbidities: avoiding infectious complications
-
19:12
biologics in ra and other rheumatic diseases
-
32:50
advances in rheumatoid arthritis
-
30:46
tb in the biologic era
-
33:10
the emerging role of the immune microenvironment in hematological malignancies
-
57:28
biologics across immune mediated inflammatory disease from the rheumatology perspective
-
4:08
risks and benefits of biologic medications
-
20:37
stopping biologics – can we do it successfully?
-
17:37
update on safety of biologics - ep. 1
-
23:43
treating to target 2015 – what are the guidelines and what is the target?
-
29:46
implementing best practices for patient communication to ensure adherence to biologic therapy
-
21:04
risks of malignancies due to ibd and immunomodulators and/or biologic therapy
-
23:40
cardiovascular aspects of rheumatic diseases -- ep. 16 of 32
-
35:38
infections associated with biologic therapies -- olga klinkova, md
-
11:29
all you need to know about biologics - how they work, when to use them and the common side effects
-
30:39
herpes zoster and the risk of stroke in patients with autoimmune diseases